Diabetes Mellitus Type 1 Perspective

• Red Flags to Watch for in Diagnosing T1D in Kids January sees the highest number of newly diagnosed type 1 diabetes cases in kids. Dr Jessica Lilley reviews the warning signs to ensure timely diagnosis.
  Medscape Diabetes & Endocrinology, January 23, 2023
• IDF 2022 Read clinically focused news coverage of key developments from IDF 2022
  Medscape Diabetes & Endocrinology, December 06, 2022
• 'First Step' Toward Delaying Progression of Type 1 Diabetes   Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes.
  Medscape Diabetes & Endocrinology, November 22, 2022
• Discoveries in Diabetic Embryogenesis Thomas R. Moore, MD, discusses innovations in the care of women with diabetes who are pregnant.
  MDedge, November 16, 2022
• Landmark Study Assesses Treatments for Type 2 Diabetes Few data have been available for analyzing the best treatments in type 2 diabetes. Dr Plotzker discusses a landmark study that assesses available options to inform clinicians' choices.
  Medscape Diabetes & Endocrinology, November 08, 2022
• Nurses Questions Answered: When Politics Divides the Team An experienced nurse discusses workplace issues, including political differences, privacy violations, and whether staff should hide their medical devices.
  Medscape Nurses, October 21, 2022
• Does Spinal Cord Stimulation Improve Diabetic Neuropathy?   Rod S. Taylor, MSc, PhD, discusses a recent trial using spinal cord stimulation for painful diabetic neuropathy and its potential for long-term use in improving pain and quality of life.
  Medscape Diabetes & Endocrinology, October 19, 2022
• How Well Do Your Patients With Diabetes Cope With Change?   Does glycemic control improve in patients with better psychological resilience? Yes and no, reports Simon M. Brackley, MD, who provides an overview of new findings.
  Medscape Diabetes & Endocrinology, October 14, 2022
• 'Urgent Low Soon' Alert Decreases Hypoglycemia After Exercise in T1D   Sian Rilstone, BSc, MSc, discusses the benefits of the "urgent low soon" alert for continuous glucose monitoring on hypoglycemia after exercise in patients with type 1 diabetes.
  Medscape Diabetes & Endocrinology, October 10, 2022
• EASD 2022 'Patients Need a Champion' for Their Diabetes Care   How do you advocate for your patients? How do you make sure their care is equitable? Anne L. Peters, MD, discusses the importance of advocacy.
  Medscape Diabetes & Endocrinology, October 03, 2022
• Reducing Waste, Going Green With Diabetes Technology   What are the initiatives to decrease waste from diabetes technology? Lutz Heinemann, PhD, discusses steps to move toward green diabetes.
  Medscape Diabetes & Endocrinology, September 29, 2022
• The Bionic Pancreas Triumphs in Pivotal Trial   We are closer than ever to a truly hands-free closed-loop insulin delivery system for type 1 diabetes.
  Medscape, September 28, 2022
• Remission Is a Worthy Goal in Type 2 Diabetes Dr Robert Gabbay, chief medical officer of the American Diabetes Association, explains why remission, not reversal, needs to be the goal for type 2 diabetes.
  Medscape Diabetes & Endocrinology, September 15, 2022
• EASD 2022 Read clinically focused news coverage of key developments from EASD 2022
  Medscape Diabetes & Endocrinology, September 14, 2022
• FreeStyle Libre 3: 'Almost Like Wearing Nothing'   Dr Anne Peters offers insight into her patients' reactions to the FreeStyle Libre 3 CGM, the smallest sensor available.
  Medscape Diabetes & Endocrinology, September 06, 2022
• Guidelines on GLP1RAs and Glucose Monitors Irl B. Hirsch, MD, reviews new guidelines for glucose monitors and inhibitors.
  MDedge, August 30, 2022
• Earlier Is Better: Treat Patients Before Type 2 Diabetes Develops   Ralph DeFronzo, MD, discusses treating type 2 diabetes early and using drugs to correct the pathophysiologic disturbances associated with it.
  Medscape Diabetes & Endocrinology, August 26, 2022
• Integrated Care and New Technologies in Type 1 Diabetes   Chantal Mathieu, MD, PhD, discusses access to care, integrated care, and new technologies in type 1 diabetes.
  Medscape Diabetes & Endocrinology, August 25, 2022
• Automated Insulin Delivery: The Next Generation of Research   Greg Forlenza, MD, discusses the next generation of automated insulin delivery research.
  Medscape Diabetes & Endocrinology, August 23, 2022
• What's New and Upcoming in CGMs?   Jennifer Sherr, MD, PhD, discusses advances in continuous glucose monitoring technologies, including current and anticipated FDA approvals, and what this means for patients.
  Medscape Diabetes & Endocrinology, August 19, 2022